Bristol-Myers Squibb vs Google: Founders, CEOs and History
Bristol-Myers Squibb was founded in 1887 by Edward Robinson Squibb, William McLaren Bristol, John Ripley Myers and is led by Christopher Boerner. Google was founded in 1998 by Larry Page, Sergey Brin and is led by Sundar Pichai.
Company facts
Bristol-Myers Squibb
- Founded
- 1887
- Headquarters
- Princeton, New Jersey
- Current CEO
- Christopher Boerner
- Employees
- 32,500
- Founded
- 1998
- Headquarters
- Mountain View, California
- Current CEO
- Sundar Pichai
- Employees
- 190,820
Founders
Bristol-Myers Squibb
Edward Robinson Squibb
Squibb resigned his Navy post and opened a small laboratory in Brooklyn in 1858 to make pure ether, chloroform and other medicines.
William McLaren Bristol
In 1887 Bristol and Myers bought the Clinton Pharmaceutical Company of Clinton, New York, reportedly for about $5,000.
John Ripley Myers
Myers and Bristol bought the Clinton Pharmaceutical Company in Clinton, New York, in 1887 and renamed it Bristol, Myers and Company in 1898.
Larry Page
Google possesses arguably the most famous, influential founding story in the history of Silicon Valley, rooted in the academic environment of Stanford University and a foundational obsession with organizing all of human knowledge.
Sergey Brin
Sergey Brin co-founded Google and played a central role in the early engineering, product, and cultural development of the company. He helped build the search technology, recruit technical talent, and preserve a culture that valued bold experiments.
CEOs and their tenures
Bristol-Myers Squibb
- Charles A. Heimbold Jr.1994–2001
Chief Executive Officer
Serving as CEO from 1994 to 2001, he aggressively expanded the company's oncology portfolio, notably launching the blockbuster cancer drug Taxol, which drove massive revenue growth.
Source - Peter R. Dolan2001–2006
Chief Executive Officer
Dolan, who had run the consumer products and medical device divisions, succeeded Charles Heimbold in May 2001. His tenure included the ImClone partnership on the cancer drug Erbitux and a federal investigation into wholesaler inventory practices.
Source - James M. Cornelius2006–2010
Chief Executive Officer
Cornelius took over after Peter Dolan's removal in September 2006 and ran the company until May 2010.
Source - Lamberto Andreotti2010–2015
Chief Executive Officer
Andreotti, previously president and chief operating officer, became CEO on May 4, 2010.
Source - Giovanni Caforio2015–2023
Chief Executive Officer
Caforio, a physician, succeeded Lamberto Andreotti in May 2015. He led the $74 billion Celgene acquisition in 2019, the $13.1 billion MyoKardia deal in 2020 and the $4.1 billion Turning Point deal in 2022, and agreed the Mirati purchase in October 2023.
Source - Chris Boerner2023–present
Board Chair and Chief Executive Officer
Boerner became CEO in November 2023 and board chair on April 1, 2024, after serving as executive vice president, chief operating officer and CEO-designate from April 2023 and earlier as chief commercialization officer.
Source
- Larry Page1998–2019
Co-founder and Former CEO
Larry Page is one of the most consequential technologists of the modern era. His initial algorithmic breakthrough organized the chaotic early internet, creating the essential infrastructure for the modern digital economy.
Source - Eric Schmidt2001–2011
Former CEO and Executive Chairman
Schmidt was the indispensable bridge between a chaotic academic research project and a globally dominant, publicly traded corporation.
Source - Sundar Pichai2015–present
CEO of Alphabet and Google
Pichai provides crucial corporate stability and pragmatic product leadership, transitioning Google from its chaotic early years into a profitable, mature corporate giant.
Source
Timeline: Bristol-Myers Squibb and Google side by side
1858Bristol-Myers Squibb
Edward Robinson Squibb opens his Brooklyn laboratory
Navy surgeon Edward Robinson Squibb started making pure ether and other medicines in Brooklyn. The laboratory burned down on Christmas Eve 1858 and reopened in 1859 after local doctors and surgeons contributed $2,100.
1887Bristol-Myers Squibb
Bristol and Myers buy the Clinton Pharmaceutical Company
Hamilton College graduates William McLaren Bristol and John Ripley Myers bought the Clinton Pharmaceutical Company of Clinton, New York, the business that became Bristol-Myers.
1898Bristol-Myers Squibb
Bristol, Myers and Company is named
The founders renamed the business Bristol, Myers and Company in May 1898. After Myers died in 1899 it became Bristol-Myers, which built national brands in Sal Hepatica and, from 1901, Ipana toothpaste.
1944Bristol-Myers Squibb
Penicillin at wartime scale
Squibb opened what was then the world's largest penicillin plant in New Brunswick, New Jersey. Bristol-Myers had bought Cheplin Biological Laboratories in East Syracuse, New York, in 1943 and converted it to penicillin for Allied forces.
1989Bristol-Myers Squibb
Bristol-Myers and Squibb merge
Bristol-Myers and Squibb combined to form Bristol-Myers Squibb, uniting a consumer and pharmaceutical company with a research-led drugmaker.
1998Google
Google Founded
Larry Page and Sergey Brin founded Google after developing PageRank at Stanford University. The search engine ranked web pages by link authority, which made results feel more relevant than portal-era competitors.
2000Google
AdWords Launch
Google launched AdWords in 2000 and connected advertising to search intent. Businesses could pay to appear near relevant queries, eventually through auction-based performance advertising.
2004Google
Google IPO
Google went public in 2004 using an auction process and priced 19,605,052 shares at $85, raising about $1.67B. The IPO gave the company capital for hiring, data centers, acquisitions, and global expansion.
2005Google
Android Acquisition
Google acquired Android in 2005 to secure a role in mobile operating systems before smartphones became the main internet device. Android later gave Google global reach through manufacturers such as Samsung and many others.
2006Bristol-Myers Squibb
CEO Peter Dolan removed over the Plavix deal
After an FBI raid in July 2006 over a patent settlement with generic maker Apotex on the blood thinner Plavix, the federal monitor urged the board to remove CEO Peter Dolan, who stepped down on September 12, 2006.
2006Google
YouTube Acquisition
Google closed the YouTube acquisition in 2006 for stock valued at $1.65B. The deal gave Google a user-generated video platform, creator ecosystem, and advertising surface outside text search before online video had a mature business model.
2008Google
DoubleClick Acquisition
Google acquired DoubleClick for $3.1B to expand its advertising infrastructure beyond search. The deal strengthened display advertising, ad serving, and publisher relationships. It helped Google build a broader ad-tech stack.
2009Bristol-Myers Squibb
Medarex bought and Mead Johnson split off
BMS bought Medarex, gaining Yervoy and a share of what became Opdivo, and split off Mead Johnson Nutrition in an exchange offer, completing its shift to a specialty biopharmaceutical company.
2011Bristol-Myers Squibb
FDA approves Yervoy
Yervoy (ipilimumab) became the first drug shown to extend overall survival in advanced melanoma, opening BMS's immuno-oncology franchise.
2012Bristol-Myers Squibb
FDA approves Eliquis
The FDA approved Eliquis (apixaban), developed with Pfizer, in December 2012 for stroke prevention in non-valvular atrial fibrillation. It became BMS's largest product, with $14.4 billion of sales in 2025.
2014Bristol-Myers Squibb
FDA approves Opdivo
The FDA approved the PD-1 inhibitor Opdivo (nivolumab) in December 2014 for advanced melanoma. It reached $10.0 billion of sales in 2025.
2014Google
DeepMind Acquisition
Google acquired DeepMind in 2014 to deepen its artificial intelligence research bench. DeepMind later became known for AlphaGo and other breakthroughs in reinforcement learning and scientific AI.
2015Google
Alphabet Restructuring
Google restructured into Alphabet Inc. In 2015, separating core Google from Other Bets. The move gave investors clearer visibility into Search, YouTube, Android, and Cloud economics while preserving room for Waymo, Verily, Calico, and X.
2019Bristol-Myers Squibb
Celgene acquisition closes
BMS completed its $74 billion purchase of Celgene on November 20, 2019, adding Revlimid, Pomalyst, Reblozyl and CAR-T programs. Celgene sold Otezla to Amgen for $13.4 billion to win regulatory approval.
2019Google
Sundar Pichai Becomes Alphabet CEO
Sundar Pichai became CEO of Alphabet in 2019 after Larry Page and Sergey Brin stepped back from daily operations. Pichai inherited a company facing cloud competition, antitrust scrutiny, privacy pressure, and rising AI expectations.
2020Bristol-Myers Squibb
MyoKardia deal and a GAAP loss
BMS bought MyoKardia for $13.1 billion, gaining mavacamten (Camzyos). The deal's $11.4 billion in-process R&D charge pushed 2020 to a net loss despite $42.5 billion of revenue.
2022Bristol-Myers Squibb
Turning Point bought as Revlimid generics arrive
BMS completed the $4.1 billion purchase of Turning Point Therapeutics in August 2022 while volume-limited generic lenalidomide began eroding Revlimid, which had peaked at $12.8 billion in 2021.
2023Bristol-Myers Squibb
Chris Boerner becomes CEO
Chris Boerner succeeded Giovanni Caforio as chief executive in November 2023 and became board chair on April 1, 2024. Weeks earlier BMS had agreed to buy Mirati, and in December it agreed to buy Karuna and RayzeBio.
2023Google
Google DeepMind Integration
Alphabet combined major AI research efforts under Google DeepMind to accelerate frontier model development. The move followed competitive pressure from OpenAI and Microsoft.
2024Bristol-Myers Squibb
Karuna, Mirati and RayzeBio close; Cobenfy approved
The three deals closed between January and March 2024. On September 26, 2024 the FDA approved Cobenfy, the first schizophrenia drug that targets muscarinic rather than dopamine receptors. The Karuna charge produced an $8.9 billion net loss for 2024.
2025Bristol-Myers Squibb
BioNTech partnership, Orbital deal and $48.2B revenue
BMS agreed in June 2025 to co-develop BioNTech's bispecific BNT327 and in October 2025 to buy Orbital Therapeutics for $1.5 billion. Full-year revenue was $48.2 billion with the Growth Portfolio up 17 percent.
2025Google
FY2025 Revenue Tops $402B
Alphabet reported FY2025 revenue of $402.836B and net income of $132.170B. The milestone showed that Search ads, YouTube, Cloud, and subscriptions kept scaling despite regulatory and AI disruption concerns.
2026Bristol-Myers Squibb
Guidance raised and merger reports denied
On July 30, 2026 BMS raised its 2026 revenue guidance to $49.0 to $50.0 billion after second-quarter revenue of $12.97 billion. In August, reports of AstraZeneca merger talks were followed by a senior source telling Reuters there were no discussions.
Acquisitions
Bristol-Myers Squibb
- Orbital Therapeutics2025$1.5B
- Mirati Therapeutics2024$4.8B
- RayzeBio2024$4.1B
- Karuna Therapeutics2024$14B
- Turning Point Therapeutics2022$4.1B
- MyoKardia2020$13.1B
- Wiz2025$32B
- Mandiant2022$5.4B
- Fitbit2021$2.1B
- DeepMind2014$500M
- DoubleClick2008$3.1B
- YouTube2006$1.6B
Questions about Bristol-Myers Squibb vs Google
Who is the CEO of Bristol-Myers Squibb Company and Alphabet Inc.?
Bristol-Myers Squibb Company is led by Christopher Boerner and Alphabet Inc. is led by Sundar Pichai. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Bristol-Myers Squibb Company founded vs Alphabet Inc.?
Bristol-Myers Squibb Company was founded in 1887 — 111 years before Alphabet Inc., which was founded in 1998. Bristol-Myers Squibb Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Alphabet Inc..
How many employees does Bristol-Myers Squibb Company have compared to Alphabet Inc.?
Bristol-Myers Squibb Company employs approximately 32,500 people, while Alphabet Inc. employs approximately 190,820. Alphabet Inc. has the larger workforce at 190,820 employees, compared to Bristol-Myers Squibb Company's 32,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Bristol-Myers Squibb Company and Alphabet Inc. headquartered?
Both Bristol-Myers Squibb Company and Alphabet Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Bristol-Myers Squibb Company and Alphabet Inc.?
Bristol-Myers Squibb Company was founded by Edward Robinson Squibb, William McLaren Bristol, John Ripley Myers. Alphabet Inc. was founded by Larry Page, Sergey Brin.
Which company has a longer operating history — Bristol-Myers Squibb Company or Alphabet Inc.?
Bristol-Myers Squibb Company has been operating for approximately 139 years, making it the more established of the two companies. Alphabet Inc. has been in operation for around 28 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bristol-Myers Squibb vs Google overview